1 / 6

Menopause and Metabolic Syndrome

Menopause and Metabolic Syndrome. Prof. Sunila Khandelwal. Metabolic Syndrome An Epidemic and increasing worldwide. Met S is a rising disease entity, still remains under diagnosed. 1.5‑2 times more common in women than in men. May develop in women in their menopausal transition years .

robertoa
Download Presentation

Menopause and Metabolic Syndrome

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Menopause and Metabolic Syndrome Prof. Sunila Khandelwal

  2. Metabolic Syndrome An Epidemic and increasing worldwide • Met S is a rising disease entity, still remains under diagnosed. • 1.5‑2 times more common in women than in men. • May develop in women in their menopausal transition years . • More common over the age of 55 years with significant rise in risk factors during postmenopausal phase. • Higher in Asian than Caucasian women, resulting in an enormous health, social and economic burden which is threatening to overwhelm the health care systems. LejskovaM etal,Climacteric 2011;13:83-91

  3. Learning objective • Highlight the prevalence of MetS. • Identify reasons and the key metabolic issues based on recent research. • Discuss updated guidelines and preventive strategies. • Focus on aggressive early therapy for achieving targets. Clinicians should increase their awareness of the metabolic derangements associated with the syndrome, Consider them when weighing MHT options andalso while considering management of individual parameters of syndrome.

  4. Challenge is to understand its pathogenesis and to identify effective measures to prevent it either at the population level or at the individual level in any of the country / region. • What are the key metabolic issues in women? • Why should we focus on aggressive early therapy? • How should we achieve targets?

  5. Menopause & Metabolic Syndrome Characterized by clustering of metabolic conditions, Menopause itself contributes to the development of this syndrome

  6. Adverse metabolic changes occurring at menopause transition as a consequence of declining of ovarian sex steroids, increases the risk of CVD and stroke 3 times, DM type II 5 times

More Related